Pancreatic Cancer Research

ResearcherThe University of Texas MD Anderson Cancer CenterActive in the last 2 years

Manal M. Hassan

Matched on ORCID iD 0000-0002-8413-449X; OpenAlex author ID A5115883202. Sources: OpenAlex.

Their work

Papers
21 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
16
Papers, trials and grants by year

2011: 2 papers · 2012: 2 papers · 2013: 1 paper · 2014: 1 paper · 2015: 4 papers · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 1 paper

Papers 21

  1. Different diabetes types and pancreatic ductal adenocarcinoma: a Mendelian randomization and pathway/gene-set analysis. Co-author DOI 10.1093/jnci/djaf308↗
  2. Genome-Wide Analysis to Assess if Heavy Alcohol Consumption Modifies the Association between SNPs and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-24-0096↗
  3. Genetic Susceptibility to Nonalcoholic Fatty Liver Disease and Risk for Pancreatic Cancer: Mendelian Randomization. Co-author DOI 10.1158/1055-9965.epi-23-0453↗
  4. Dietary Intake of Fatty Acids and Risk of Pancreatic Cancer: A Case-Control Study. Co-author DOI 10.1093/jn/nxab372↗
  5. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. Co-author DOI 10.1093/ajcn/nqab217↗
  6. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗
  7. Mendelian Randomization Analysis of n-6 Polyunsaturated Fatty Acid Levels and Pancreatic Cancer Risk. Co-author DOI 10.1158/1055-9965.epi-20-0651↗
  8. Dietary N-nitroso compounds and risk of pancreatic cancer: results from a large case-control study. Co-author DOI 10.1093/carcin/bgy169↗
  9. Vitamin C and Vitamin E Mitigate the Risk of Pancreatic Ductal Adenocarcinoma from Meat-Derived Mutagen Exposure in Adults in a Case-Control Study. Last author DOI 10.1093/jn/nxz081↗
  10. Genetic polymorphisms associated with pancreatic cancer survival: a genome-wide association study. Co-author DOI 10.1002/ijc.30762↗
  11. Three new pancreatic cancer susceptibility signals identified on chromosomes 1q32.1, 5p15.33 and 8q24.21. Co-author DOI 10.18632/oncotarget.11041↗
  12. Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer. Co-author DOI 10.1038/ng.3341↗
  13. Vitamin D metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0117574↗
  14. Correction: vitamin d metabolic pathway genes and pancreatic cancer risk. Co-author DOI 10.1371/journal.pone.0129983↗
  15. Impacts of new-onset and long-term diabetes on clinical outcome of pancreatic cancer. Co-author PMID 26693076↗
  16. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Co-author DOI 10.1038/ng.3052↗
  17. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. Co-author DOI 10.1371/journal.pone.0072311↗
  18. Association of diabetes and perineural invasion in pancreatic cancer. Co-author DOI 10.1002/cam4.43↗
  19. Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-11-2994↗
  20. Diabetes and risk of pancreatic cancer: a pooled analysis of three large case-control studies. Co-author DOI 10.1007/s10552-010-9686-3↗
  21. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Co-author DOI 10.1158/1055-9965.epi-10-0845↗

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Donghui Li · 9 shared papers, 2011–2022 · strength 0.70
  2. Carrie R. Daniel · 3 shared papers, 2019–2022 · strength 0.43
  3. Jiali Zheng · 3 shared papers, 2019–2022 · strength 0.43
  4. Hongwei Tang · 3 shared papers, 2017–2019 · strength 0.30
  5. Peng Wei · 2 shared papers, 2017–2019 · strength 0.19
  6. James L. Abbruzzese · 4 shared papers, 2011–2015 · strength 0.16
  7. Ping Chang · 2 shared papers, 2015–2017 · strength 0.13
  8. Hongwei Tang · 2 shared papers, 2011 · strength 0.06
  9. Yixiang Mao · 1 shared paper, 2015 · strength 0.06
  10. Navid Sadeghi · 1 shared paper, 2012 · strength 0.04
  11. Steven A. Curley · 1 shared paper, 2012 · strength 0.03
  12. Motofumi Tanaka · 1 shared paper, 2012 · strength 0.03
  13. İbrahim Halil Şahin · 1 shared paper, 2012 · strength 0.03
  14. Xiaoqun Dong · 1 shared paper, 2011 · strength 0.03
  15. Debra T. Silverman · 1 shared paper, 2011 · strength 0.03
  16. Paige M. Bracci · 1 shared paper, 2011 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.